The cost of healthcare drives stakeholder interest in reimbursement. Before investors risk their money, they want to know about coverage, coding, and payment. Payers expect better outcomes at equal or lower cost. Hospitals are establishing value analysis committees. Physicians want products that help them meet metrics. And patients are becoming more educated and prefer interventions that improve quality of life at the lowest cost.

Until recently the main focus for health technology companies was FDA clearance. That is still important, but reimbursement is now a top concern. Join this session to learn the basics of reimbursement and how you can develop an integrated clinical plan.